Vicarious Surgical (RBOTW) Shares Outstanding (Weighted Average) (2020 - 2025)
Vicarious Surgical (RBOTW) reported Shares Outstanding (Weighted Average) of $27.6 million for Q4 2025, little changed year-over-year from $27.6 million in Q4 2024, and little changed on a QoQ basis from $27.6 million in Q3 2025.
Vicarious Surgical (RBOTW) has 6 years of Shares Outstanding (Weighted Average) data on file, last reported at $27.6 million in Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $27.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.6 million (changed 0.0% YoY) and the FY2025 annual result came in at $27.6 million, changed 0.0% from the prior year.
- Shares Outstanding (Weighted Average) held at $27.6 million in Q4 2025 per RBOTW's latest filing, from $27.6 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $126.1 million in Q1 2023 and bottomed at $4.2 million in Q2 2023.
- The 5-year median for Shares Outstanding (Weighted Average) is $27.6 million (2023), against an average of $57.3 million.
- The widest annual swing landed in 2021, when Shares Outstanding (Weighted Average) surged 1069.02%; it then sank 96.51% in 2023.
- Tracing RBOTW's Shares Outstanding (Weighted Average) over 5 years: stood at $96.7 million in 2021, then climbed by 25.96% to $121.8 million in 2022, then slumped by 77.3% to $27.6 million in 2023, then changed by 0.0% to $27.6 million in 2024, then changed by 0.0% to $27.6 million in 2025.
- Per Business Quant, the three latest RBOTW Shares Outstanding (Weighted Average) figures stand at $27.6 million (Q4 2025), $27.6 million (Q3 2025), and $27.6 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Vicarious Surgical | - | - | - | 27.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.65 Mn |
| Sep 30, 2025 | 27.65 Mn |
| Jun 30, 2025 | 27.65 Mn |
| Mar 31, 2025 | 5.92 Mn |
| Dec 31, 2024 | 27.65 Mn |
| Sep 30, 2024 | 5.88 Mn |
| Jun 30, 2024 | 5.87 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 27.65 Mn |
| Sep 30, 2023 | 5.17 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 126.13 Mn |
| Dec 31, 2022 | 121.79 Mn |
| Sep 30, 2022 | 121.97 Mn |
| Jun 30, 2022 | 120.81 Mn |
| Mar 31, 2022 | 120.28 Mn |
| Dec 31, 2021 | 96.69 Mn |
| Sep 30, 2021 | 92.23 Mn |
| Jun 30, 2021 | 87.68 Mn |
| Mar 31, 2021 | 87.51 Mn |
| Dec 31, 2020 | 26.15 Mn |
| Sep 30, 2020 | 34.09 Mn |
| Jun 30, 2020 | 7.50 Mn |